在帕金森病中,白质微观结构变化和大脑代谢分布在帕金森病中
Mengjiao Wang1, Yansong Liu1, Wei Han1
1Department of Nuclear Medicine, 1 st Hospital of Harbin Medical University, 23 Post Street, Harbin, 15000, Heilongjiang Province, China.
Brain imaging and behavior
|June 3, 2025
概括
这项研究将帕金森病 (PD) 患者的白质变化与大脑葡萄糖代谢的改变联系起来. 使用先进的成像技术,研究人员发现了PD的特定微观结构和代谢差异,为疾病病理学提供了洞察力.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 医学物理 医学物理
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特点是运动和非运动症状.
- 白质微观结构的改变和大脑葡萄糖代谢的变化都与PD的发病有关.
- 同时的18F-FDG PET/MRI提供了一种多模式的方法来同时调查这些变化.
研究的目的:
- 在帕金森病 (PD) 患者中研究白质微观结构和大脑葡萄糖代谢之间的关系.
- 使用自动纤维量化 (AFQ) 与同时使用18F-FDG PET/MRI来分析这些参数.
- 为了确定PD病理学的潜在成像生物标志物.
主要方法:
- 同时对23名PD患者和15名健康对照 (HC) 进行了18F-FDG PET/MRI扫描.
- 自动纤维量化 (AFQ) 用于评估白质通道的通道智能扩散特性.
- 收集和分析了临床数据和认知评估 (MMSE,MoCA).
主要成果:
- 与HC相比,PD患者的MMSE和MoCA得分较低.
- 在PD患者的右皮质脊髓管 (CST) 中观察到平均扩散率 (MD) 和轴向扩散率 (AD) 的增加.
- 患有PD的患者在右侧偏中心叶片和双侧膜中表现出高代谢,在右侧皮质中表现出低代谢.
- 右侧中心叶片的高代谢与中枢神经系统的微观结构变化 (MD和AD) 有正相关.
结论:
- 帕金森病与明显的白质微观结构变化和改变的葡萄糖代谢模式有关.
- 这些发现表明,在PD中,CST完整性与对中心叶片中的代谢活动之间存在联系.
- 这种多式成像方法为PD的神经生物学基础提供了宝贵的见解.
相关概念视频
Parkinson's Disease: Overview
723
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
723
Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
Alzheimer's Disease: Overview
686
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
686


